{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:38:37Z","timestamp":1787020717314,"version":"build-2736575974"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,1,10]],"date-time":"2020-01-10T00:00:00Z","timestamp":1578614400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,1,10]],"date-time":"2020-01-10T00:00:00Z","timestamp":1578614400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>The interest in patient demographics and disease management has increased in the past years due to their utility in developing measures that allow healthcare providers to reflect disease complexity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To revise the current status of spinal muscular atrophy in the region of Catalonia, and to validate the utility of the database for this aim.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Five hundred twenty-four patients diagnosed with a spinal muscular atrophy were identified in the region of Catalonia via the novel program of data analysis for research and innovation in health (PADRIS). Patient records included in the analysis corresponded to primary care, hospital, emergency room, extended care and mental health admissions between 2007 and 2017.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>58.02% of patients with a SMA diagnosis were males while 40.84% were females. Average age of diagnosis was 38.31\u2009\u00b1\u200924.49\u2009years \u00b1SD. Significantly lower was the age of diagnosis of spinal muscular atrophy type I, 1.81\u2009\u00b1\u20093.01\u2009years. An average of 22 patients died per year during the study period, with a mean decease age of 62.96\u2009\u00b1\u200925.41\u2009years. Patients were generally attended in hospitals, and the use of healthcare resources was focused on resolving respiratory issues and scoliosis. The highest ratio of admissions per patient was registered in those aged 0 to 4\u2009years. Patients presented a higher risk than the general population and a higher frequency of multimorbidites.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Patients exhibited similar characteristics to prior European studies. Multiple admissions in younger patients, mostly due to respiratory issues, have a central role in increasing medical costs of SMA. Equally, the higher risk of patients and increased number of multimorbidity groups translate in an elevated number of admissions in health centres and ER, deriving in higher expenses.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13023-019-1287-y","type":"journal-article","created":{"date-parts":[[2020,1,10]],"date-time":"2020-01-10T11:02:59Z","timestamp":1578654179000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Management and current status of spinal muscular atrophy: a retrospective multicentre claims database analysis"],"prefix":"10.1186","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2371-0999","authenticated-orcid":false,"given":"Josep","family":"Darb\u00e0","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,1,10]]},"reference":[{"issue":"4","key":"1287_CR1","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/j.ncl.2015.07.004","volume":"33","author":"SJ Kolb","year":"2015","unstructured":"Kolb SJ, Kissel JT. Spinal muscular atrophy. Neurol Clin. 2015;33(4):831\u201346.","journal-title":"Neurol Clin"},{"issue":"4","key":"1287_CR2","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1001\/archneur.64.4.522","volume":"64","author":"J Visser","year":"2007","unstructured":"Visser J, van den Berg-Vos RM, Franssen H, van den Berg LH, Wokke JH, de Jong JM, et al. Disease course and prognostic factors of progressive muscular atrophy. Arch Neurol. 2007;64(4):522\u20138.","journal-title":"Arch Neurol"},{"key":"1287_CR3","unstructured":"Spinal Dystrophy Association. Available at: https:\/\/www.mda.org Last accessed 4 Mar 2019."},{"issue":"11","key":"1287_CR4","first-page":"113","volume":"6","author":"G Haaker","year":"2013","unstructured":"Haaker G, Fujak A. Proximal spinal muscular atrophy: current orthopedic perspective. Appl Clin Genet. 2013;6(11):113\u201320.","journal-title":"Appl Clin Genet"},{"issue":"8","key":"1287_CR5","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1177\/0883073807305673","volume":"22","author":"BS Russman","year":"2007","unstructured":"Russman BS. Spinal muscular atrophy: clinical classification and disease heterogeneity. J Child Neurol. 2007;22(8):946\u201351.","journal-title":"J Child Neurol"},{"issue":"7","key":"1287_CR6","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1002\/ajmg.a.33474","volume":"152A","author":"TW Prior","year":"2010","unstructured":"Prior TW, Snyder PJ, Rink BD, Pearl DK, Pyatt RE, Mihal DC, et al. Newborn and carrier screening for spinal muscular atrophy. Am J Med Genet A. 2010;152A(7):1608\u201316.","journal-title":"Am J Med Genet A"},{"issue":"1","key":"1287_CR7","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/s13023-017-0671-8","volume":"12","author":"IEC Verhaart","year":"2017","unstructured":"Verhaart IEC, Robertson A, Wilson IJ, Aartsma-Rus A, Cameron S, Jones CC. Prevalence, incidence and carrier frequency of 5q\u2013linked spinal muscular atrophy \u2013 a literature review. Orphanet J Rare Dis. 2017;12(1):124.","journal-title":"Orphanet J Rare Dis"},{"issue":"7","key":"1287_CR8","doi-asserted-by":"publisher","first-page":"e0201004","DOI":"10.1371\/journal.pone.0201004","volume":"13","author":"A Chabanon","year":"2018","unstructured":"Chabanon A, Seferian AM, Daron A, P\u00e9r\u00e9on Y, Cances C, Vuillerot C, et al. Prospective and longitudinal natural history study of patients with type 2 and 3 spinal muscular atrophy: baseline data NatHis-SMA study. PLoS One. 2018;13(7):e0201004.","journal-title":"PLoS One"},{"key":"1287_CR9","unstructured":"Programa p\u00fablic d\u2019anal\u00edtica de dades per a la recerca i la innovaci\u00f3 en salut a Catalunya \u2013PADRIS\u2013. Barcelona: Ag\u00e8ncia de Qualitat i Avaluaci\u00f3 Sanit\u00e0ries de Catalunya. Departament de Salut. Generalitat de Catalunya; 2017."},{"issue":"10","key":"1287_CR10","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1016\/j.aprim.2016.06.003","volume":"48","author":"D Monterde","year":"2016","unstructured":"Monterde D, Vela E, Cl\u00e8ries M, Grupo colaborativo GMA. Adjusted morbidity groups: a new multiple morbidity measurement of use in primary care. Atenci\u00f3n Primaria. 2016;48(10):674\u201382.","journal-title":"Atenci\u00f3n Primaria"},{"issue":"5","key":"1287_CR11","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1111\/j.1524-4733.2007.00186.x","volume":"10","author":"LP Garrison Jr","year":"2007","unstructured":"Garrison LP Jr, Neumann PJ, Erickson P, Marshall D, Mullins CD. Using real-world data for coverage and payment decisions: the ISPOR real-world data task force report. Value Health. 2007;10(5):326\u201335.","journal-title":"Value Health"},{"key":"1287_CR12","unstructured":"Orphanet, The portal for rare diseases and orphan drugs. Retrieved from: https:\/\/www.orpha.net\/consor\/cgi-bin\/index.php?lng=EN Last accessed 4 Mar 2019."},{"issue":"1","key":"1287_CR13","doi-asserted-by":"publisher","first-page":"103","DOI":"10.18388\/abp.2009_2521","volume":"56","author":"M Jedrzejowska","year":"2009","unstructured":"Jedrzejowska M, Milewski M, Zimowski J, Borkowska J, Kostera-Pruszczyk A, Sielska D, et al. Phenotype modifiers of spinal muscular atrophy: the number of SMN2 gene copies, deletion in the NAIP gene and probably gender influence the course of the disease. Acta Biochim Pol. 2009;56(1):103\u20138.","journal-title":"Acta Biochim Pol"},{"issue":"1","key":"1287_CR14","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/jhg.2013.111","volume":"59","author":"C Yanyan","year":"2014","unstructured":"Yanyan C, Yujin Q, Jinli B, Yuwei J, Hong W, Fang S. Correlation of PLS3 expression with disease severity in children with spinal muscular atrophy. J Hum Genet. 2014;59(1):24\u20137.","journal-title":"J Hum Genet"},{"issue":"1","key":"1287_CR15","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s00439-008-0598-1","volume":"125","author":"L Al\u00edas","year":"2009","unstructured":"Al\u00edas L, Bernal S, Fuentes-Prior P, Barcel\u00f3 MJ, Also E, Mart\u00ednez-Hern\u00e1ndez R, et al. Mutation update of spinal muscular atrophy in Spain: molecular characterization of 745 unrelated patients and identification of four novel mutations in the SMN1 gene. Hum Genet. 2009;125(1):29\u201339.","journal-title":"Hum Genet"},{"key":"1287_CR16","unstructured":"Multimorbidity: Technical Series on Safer Primary Care. Geneva: World Health Organization; 2016. Licence: CC BY-NC-SA 3.0 IGO."},{"issue":"1","key":"1287_CR17","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1186\/s13023-017-0695-0","volume":"12","author":"J L\u00f3pez-Bastida","year":"2017","unstructured":"L\u00f3pez-Bastida J, Pe\u00f1a-Longobardo LM, Aranda-Reneo I, Tizzano E, Sefton M, Oliva-Moreno J. Social\/economic costs and health-related quality of life in patients with spinal muscular atrophy (SMA) in Spain. Orphanet J Rare Dis. 2017;12(1):141.","journal-title":"Orphanet J Rare Dis."},{"issue":"8","key":"1287_CR18","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1002\/humu.20525","volume":"28","author":"UP Guenther","year":"2007","unstructured":"Guenther UP, Varon R, Schlicke M, Dutrannoy V, Volk A, H\u00fcbner C, et al. Clinical and mutational profile in spinal muscular atrophy with respiratory distress (SMARD): defining novel phenotypes through hierarchical cluster analysis. Hum Mutat. 2007;28(8):808\u201315.","journal-title":"Hum Mutat"},{"key":"1287_CR19","doi-asserted-by":"publisher","first-page":"13","DOI":"10.3389\/fped.2018.00013","volume":"6","author":"PK Bedi","year":"2018","unstructured":"Bedi PK, Castro-Codesal ML, Featherstone R, AlBalawi MM, Alkhaledi B, Kozyrskyj AL, et al. Long-term non-invasive ventilation in infants: a systematic review and meta-analysis. Front Pediatr. 2018;6:13.","journal-title":"Front Pediatr"},{"issue":"6","key":"1287_CR20","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1016\/S0022-3476(89)80740-1","volume":"115","author":"IS Gilgoff","year":"1989","unstructured":"Gilgoff IS, Kahlstrom E, MacLaughlin E, Keens TG. Long-term ventilatory support in spinal muscular atrophy. J Pediatr. 1989;115(6):904\u20139.","journal-title":"J Pediatr"},{"issue":"2","key":"1287_CR21","doi-asserted-by":"publisher","first-page":"e149","DOI":"10.1212\/WNL.0000000000007742","volume":"93","author":"CA Wijngaarde","year":"2019","unstructured":"Wijngaarde CA, Brink RC, de Kort FAS, Stam M, Otto LAM, Asselman FL, et al. Natural course of scoliosis and lifetime risk of scoliosis surgery in spinal muscular atrophy. Neurology. 2019;93(2):e149\u201358.","journal-title":"Neurology."}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-019-1287-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13023-019-1287-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-019-1287-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,8]],"date-time":"2021-01-08T20:25:11Z","timestamp":1610137511000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-019-1287-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,10]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1287"],"URL":"https:\/\/doi.org\/10.1186\/s13023-019-1287-y","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,10]]},"assertion":[{"value":"18 March 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 December 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Project approved by a bioethics committee. Patient consent was not required.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"8"}}